Fri, May 9, 1:02 PM (13 days ago)
**Cardiff Lexington Corporation (CLXN) Q1 2025 Financial Summary** **Financial Health & Performance:** - **Revenue:** $2,915,567 (up 25.56% YoY) - **Net Loss:** $450,777 (up 59.23% YoY) - **Gross Profit Margin:** 63.13% (up 3.96% YoY) - **Operating Expenses:** $1,296,599 (up 12.36% YoY) - **Cash Flow from Operations:** -$1,628,728 (up 37.12% YoY) **Key Metrics:** - **Current Assets:** $18,610,504 (up 8.69% YoY) - **Total Liabilities:** $18,230,516 (up 11.63% YoY) - **Stockholders' Equity:** $2,036,047 (down 24.16% YoY) **Quarterly Performance:** - **Revenue Growth:** Driven by increased patient volume and complex procedures. - **Profit Margins:** Improved gross margin due to better cost management. - **Cash Flow:** Negative cash flow from operations due to increased expenses and accounts receivable. **Trends & Uncertainties:** - **Revenue Growth:** Positive trend with increased patient volume. - **Expenses:** Rising costs in salaries, bad debt, and billing. - **Cash Flow:** Negative trend due to increased expenses and accounts receivable. **Future Operations Impact:** - **Funding:** Requires additional capital for operations and acquisitions. - **Acquisitions:** Plans to acquire more healthcare businesses. - **Cash Flow:** Needs to improve cash flow management to sustain operations. **Ticker:** CLXN